Back to Search
Start Over
Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren's syndrome (SS)
- Source :
- Mediterranean Journal of Rheumatology, Mediterranean Journal of Rheumatology, Vol 29, Iss 1, Pp 56-58 (2018)
- Publication Year :
- 2018
-
Abstract
- Background Development of non-Hodgkin's lymphoma (NHL) is the major adverse outcome of primary Sjogren's Syndrome (pSS) affecting both morbidity and mortality. The high frequency of transformation to lymphoid malignancy in pSS among autoimmune rheumatic diseases (6-10% of patients) and the accessibility of the affected organ (minor salivary glands; MSG), render pSS an ideal model for the study of lymphomagenesis associated with autoimmune diseases and inflammation. Although pSS-related lymphoid transformation is generally considered as an antigen-driven, multi-step process owed to the chronic activation of B-cells in MSGs, the underlying mechanisms remain elusive. Our recent results support that miR200b-5p miRNA is significantly down-regulated in the MSGs of pSS patients who have or will develop lymphoma, long before lymphoma clinical onset, indicating that it may be involved in lymphomagenesis. Aim To investigate the role of miR200b-5p miRNA in pSS-associated lymphomagenesis. Methods At first, the miR200b-5p-expression will be examined by in situ hybridization in MSGs of pSS patients who are at low risk and have not developed NHL during follow-up, high risk and developed NHL in the future (pre-lymphoma) or have NHL, and the expressing cellular types, as well as those with reduced expression during lymphomagenesis, will be identified. Then, the miR200b-5p targeted molecular pathways in those cellular types (epithelial, B-cells and/or other lymphocytes, all non-neoplastic) will be studied in in vitro experiments by over-expressing and silencing of miR200b-5p, followed by transcriptome analysis. This approach is expected to find possibly novel pathogenetic mechanisms underlying SS-related lymphomagenesis. The latter is of high significance, not only for the understanding of lymphomagenesis, but also for its reversal and/or treatment. Anticipated benefits This approach is anticipated to a) reveal the differentially regulated molecules and pathways by miR200b-5p, b) enlighten novel pathogenetic pathways underlying lymphomagenesis and c) identify novel therapeutic targets and possibly evidence-based therapeutic interventions.
- Subjects :
- Minor Salivary Glands
lcsh:Diseases of the musculoskeletal system
business.industry
Inflammation
In situ hybridization
medicine.disease
non-Hodgkin’s lymphoma
3. Good health
Non-Hodgkin's lymphoma
Lymphoma
Transcriptome
Research Protocols-Proposals
lymphomagenesis
Rheumatology
microRNA
medicine
Cancer research
Gene silencing
lcsh:RC925-935
medicine.symptom
business
minor salivary glands
Sjögren’s Syndrome
miR200b-5p miRNA
Subjects
Details
- ISSN :
- 2529198X
- Volume :
- 29
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Mediterranean journal of rheumatology
- Accession number :
- edsair.doi.dedup.....177c3dd0f2860a4b1557f9f6bd8d47d1